Mechanism of TNF-α modulation of Caco-2 intestinal epithelial tight junction barrier: role of myosin light-chain kinase protein expression
Abstract
TNF-α plays a central role in the intestinal inflammation of various inflammatory disorders including Crohn's disease (CD). TNF-α-induced increase in intestinal epithelial tight junction (TJ) permeability has been proposed as one of the proinflammatory mechanisms contributing to the intestinal inflammation. The intracellular mechanisms involved in the TNF-α-induced increase in intestinal TJ permeability remain unclear. The purpose of this study was to investigate the possibility that the TNF-α-induced increase in intestinal epithelial TJ permeability was regulated by myosin light-chain kinase (MLCK) protein expression, using an in vitro intestinal epithelial model system consisting of the filter-grown Caco-2 intestinal epithelial monolayers. TNF-α (10 ng/ml) produced a time-dependent increase in Caco-2 MLCK expression. The TNF-α increase in MLCK protein expression paralleled the increase in Caco-2 TJ permeability, and the inhibition of the TNF-α-induced MLCK expression (by cycloheximide) prevented the increase in Caco-2 TJ permeability, suggesting that MLCK expression may be required for the increase in Caco-2 TJ permeability. The TNF-α increase in MLCK protein expression was preceded by an increase in MLCK mRNA expression but not an alteration in MLCK protein degradation. Actinomycin-D prevented the TNF-α increase in MLCK mRNA expression and the subsequent increase in MLCK protein expression and Caco-2 TJ permeability, suggesting that the increase in MLCK mRNA transcription led to the increase in MLCK expression. The TNF-α increase in MLCK protein expression was also associated with an increase in Caco-2 MLCK activity. The cycloheximide inhibition of MLCK protein expression prevented the TNF-α increase in MLCK activity and Caco-2 TJ permeability. Moreover, inhibitors of MLCK, Mg 2+-myosin ATPase, and metabolic energy prevented the TNF-α increase in Caco-2 TJ permeability, suggesting that the increase in MLCK activity was required for the TNF-α-induced opening of the Caco-2 TJ barrier. In conclusion, our results indicate for the first time that 1) the TNF-α increase in Caco-2 TJ permeability was mediated by an increase in MLCK protein expression, 2) the increase in MLCK protein expression was regulated by an increase in MLCK mRNA transcription, and 3) the increase in Caco-2 TJ permeability required MLCK protein expression-dependent increase in MLCK activity.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Increased serum concentrations of TNF, IL-1β, and IL-6 are potent inducers of intestinal permeability.
“Increased serum concentrations of TNF, IL-1β, and IL-6 have also been shown to be potent inducers of intestinal permeability50–53.”
From Dietary metabolism, the gut microbiome, and heart failure (2019) · cites this paper as [52]
Cites
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
Hanauer, S. B., Feagan, B. G., Lichtenstein, G. R., Mayer, L., Schreiber, S., Colombel, J., Rachmilewitz, D., Wolf, D. C., Olson, A. D., Bao, W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08512-4 · Cited by 4,164 · see citing works
Targan, S. R., Hanauer, S. B., van Deventer, S. J. H., Mayer, L., Present, D. H., Braakman, T., DeWoody, K. L., Schaible, T. F., & Rutgeerts, P. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710093371502 · Cited by 3,135 · see citing works
Hidalgo, I. J., Raub, T. J., & Borchardt, R. T. (1989) · Gastroenterology · doi:10.1016/s0016-5085(89)80072-1 · Cited by 2,396 · see citing works
Pinto, M. (1983) · HAL · Cited by 1,752 · see citing works
Regulation and Kinetics of the Actin-Myosin-ATP Interaction
Adelstein, R. S., & Eisenberg, E. (1980) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.49.070180.004421 · Cited by 1,080 · see citing works
The Function of Myosin and Myosin Light Chain Kinase Phosphorylation in Smooth Muscle
Kamm, K. E., & Stull, J. T. (1985) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.25.040185.003113 · Cited by 1,062 · see citing works
Ma, T., Iwamoto, G. K., Hoa, N., Akotia, V., Pedram, A., Boivin, M., & Said, H. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00173.2003 · Cited by 811 · see citing works
Self-citationIncreased Intestinal Permeability in Patients with Crohn's Disease and Their Relatives
Hollander, D., Vadheim, C. M., Brettholz, E., Petersen, G. M., Delahunty, T., & Rotter, J. I. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-105-6-883 · Cited by 762 · see citing works
Tumour necrosis factor alpha in stool as a marker of intestinal inflammation
Braegger, C., Nicholls, S. J., MURCH, S. H., MacDonald, T. T., & Stephens, S. (1992) · The Lancet · doi:10.1016/0140-6736(92)90999-j · Cited by 683 · see citing works
Intestinal permeability and the prediction of relapse in Crohn's disease
Wyatt, J., Vogelsang, H., Hübl, W., Waldhoer, T., & Lochs, H. (1993) · The Lancet · doi:10.1016/0140-6736(93)90882-h · Cited by 626 · see citing works
Turner, J. R., Rill, B. K., Carlson, S. L., Carnes, D., Kerner, R., Mrsny, R. J., & Madara, J. (1997) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1997.273.4.c1378 · Cited by 553 · see citing works
MURCH, S. H., Braegger, C., Walker‐Smith, J. A., & MacDonald, T. T. (1993) · Gut · doi:10.1136/gut.34.12.1705 · Cited by 520 · see citing works
Tumour necrosis factor and Crohn's disease.
van Deventer, S. J. H. (1997) · Gut · doi:10.1136/gut.40.4.443 · Cited by 495 · see citing works
Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease
Suenaert, P., Bulteel, V., Lemmens, L., Noman, M., Geypens, B. J., Assche, G. V., Geboes, K. J., Ceuppens, J. L., & Rutgeerts, P. J. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05914.x · Cited by 402 · see citing works
Zolotarevsky, Y., Hecht, G. A., Koutsouris, A., Gonzalez, D. E., Quan, C., Tom, J., Mrsny, R. J., & Turner, J. R. (2002) · Gastroenterology · doi:10.1053/gast.2002.34235 · Cited by 385 · see citing works
Schmitz, H., Fromm, M., Bentzel, C. J., Scholz, P., Detjen, K. M., Mankertz, J., Bode, H., Epple, H., Riecken, E., & Schulzke, J. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.1.137 · Cited by 375 · see citing works
Nonsteroidal Anti-Inflammatory Drugs Activate Quiescent Inflammatory Bowel Disease
Kaufmann, H. J., & TAUBIN, H. L. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-4-513 · Cited by 351 · see citing works
Recent Developments in Nonspecific Inflammatory Bowel Disease
Kirsner, J. B., & Shorter, R. G. (1982) · New England Journal of Medicine · doi:10.1056/nejm198204013061304 · Cited by 339 · see citing works
Thalidomide therapy for patients with refractory Crohn's disease: An open-label trial
Ehrenpreis, E. D., Kane, S. V., Cohen, L. B., Cohen, R. D., & Hanauer, S. B. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70276-3 · Cited by 325 · see citing works
Is small intestinal permeability really increased in relatives of patients with Crohn's disease?
May, G. R., Sutherland, L. R., & Meddings, J. B. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90638-s · Cited by 316 · see citing works
Intestinal permeability in patients with Crohn's disease and their healthy relatives
Katz, K. D., Hollander, D., Vadheim, C. M., McElree, C. K., Delahunty, T., Dadufalza, V. D., Krugliak, P., & Rotter, J. I. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)91499-6 · Cited by 302 · see citing works
Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: a case-control study
Felder, J. B., Korelitz, B. I., Rajapakse, R. O., Schwarz, S., Horatagis, A.-P. E., & Gleim, G. M. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.02262.x · Cited by 290 · see citing works
Infliximab for Crohn's disease in clinical practice at the Mayo Clinic: the first 100 patients
Ricart, E., Panaccione, R., Loftus, E. V., Tremaine, W. J., & Sandborn, W. J. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.03612.x · Cited by 285 · see citing works
Crohn's disease--a permeability disorder of the tight junction?
Hollander, D. (1988) · Gut · doi:10.1136/gut.29.12.1621 · Cited by 271 · see citing works
Tai, H.-L., Krynetski, E. Y., Schuetz, E. G., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6444 · Cited by 263 · see citing works
Ethanol modulation of intestinal epithelial tight junction barrier
Ma, T. Y., Nguyen, D., Bui, V., Nguyen, H. B., & Hoa, N. T. (1999) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1999.276.4.g965 · Cited by 261 · see citing works
Self-citationYuhan, R., Koutsouris, A., Savkovic, S., & Hecht, G. A. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70006-4 · Cited by 239 · see citing works
Recent Developments in Nonspecific Inflammatory Bowel Disease
Kirsner, J. B., & Shorter, R. G. (1982) · New England Journal of Medicine · doi:10.1056/nejm198204083061404 · Cited by 228 · see citing works
Petrache, I., Verin, A. D., Crow, M. T., et al. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.280.6.l1168 · Cited by 222 · see citing works
Ferrier, L., Mazelin, L., Cénac, N., Desreumaux, P., Janin, A., Émilie, D., Colombel, J., Villar, R. G., Fioramonti, J., & Bueno, L. P. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)01057-6 · Cited by 197 · see citing works
Clostridium difficile toxin B disrupts the barrier function of T84 monolayers
Hecht, G. A., Koutsouris, A., Pothoulakis, C., LaMont, J. T., & Madara, J. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90085-d · Cited by 191 · see citing works
Effects of modulators of myosin light-chain kinase activity in single smooth muscle cells
Itoh, T., Ikebe, M., Kargacin, G. J., et al. (1989) · Nature · doi:10.1038/338164a0 · Cited by 153 · see citing works
Jones, V. A. (1987) · Digestive Diseases and Sciences · doi:10.1007/bf01312473 · Cited by 135 · see citing works
Elemental diets in treatment of acute Crohn's disease.
O'Morain, C. A., Segal, A. W., & Levi, A. J. (1980) · BMJ · doi:10.1136/bmj.281.6249.1173 · Cited by 134 · see citing works
Marano, C. W., Lewis, S. A., Garulacan, L. A., Soler, A. P., & Mullin, J. M. (1998) · The Journal of Membrane Biology · doi:10.1007/s002329900333 · Cited by 108 · see citing works
Cytochalasin B modulation of Caco-2 tight junction barrier: role of myosin light chain kinase
Ma, T. Y., Hoa, N. T., Tran, D., Bui, V., Pedram, A., Mills, S., & Merryfield, M. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.279.5.g875 · Cited by 108 · see citing works
Self-citationRodriguez, P., Heyman, M., Candalh, C., Blaton, M. A., & Bouchaud, C. (1995) · Cytokine · doi:10.1006/cyto.1995.0060 · Cited by 105 · see citing works
Tissue remodeling during tumor necrosis factor-induced apoptosis in LLC-PK1 renal epithelial cells
Soler, A. P., Mullin, J. M., Knudsen, K. A., et al. (1996) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1996.270.5.f869 · Cited by 104 · see citing works
Intestinal Epithelial Barrier Dysfunction in Crohn's Disease
Y, T. (1997) · Experimental Biology and Medicine · doi:10.3181/00379727-214-44099 · Cited by 100 · see citing works
Epithelial Barrier Defects in HT‐29/B6 Colonic Cell Monolayers Induced by Tumor Necrosis Factor‐α
Gitter, A. H., Bendfeldt, K., SCHMITZ, H., Schulzke, J., Bentzel, C. J., & Fromm, M. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05242.x · Cited by 86 · see citing works
IEC-18, a nontransformed small intestinal cell line for studying epithelial permeability.
Y, T., Hollander, D., Bhalla, D. R., et al. (1992) · PubMed · Cited by 75 · see citing works
Cytoskeletal regulation of Caco‐2 intestinal monolayer paracellular permeability
Ma, T. Y., Hollander, D., Tran, L., Nguyen, D., Hoa, N. T., & Bhalla, D. K. (1995) · Journal of Cellular Physiology · doi:10.1002/jcp.1041640311 · Cited by 74 · see citing works
Self-citationBiologic Therapy for Inflammatory Bowel Disease
Sands, B. E. (1997) · Inflammatory Bowel Diseases · doi:10.1002/ibd.3780030206 · Cited by 63 · see citing works
A randomized controlled study comparing elemental diet and steroid treatment in Crohn's disease
Zoli, G., CARÈ, M., Parazza, M., Spanò, C., Biagi, F., Bernardi, M., & Gasbarrini, A. (1997) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1997.t01-1-00192.x · Cited by 61 · see citing works
Ma, T. Y., Hollander, D., Riga, R., et al. (1993) · PubMed · Cited by 52 · see citing works
Self-citationAnnotation and analysis of 10,000 expressed sequence tags from developing mouse eye and adult retina
Yu, J., Farjo, R. A., MacNee, S. P., et al. (2003) · Genome biology · doi:10.1186/gb-2003-4-10-r65 · Cited by 44 · see citing works
Biologic Therapy for Inflammatory Bowel Disease
Sands, B. E. (1997) · Inflammatory Bowel Diseases · doi:10.1097/00054725-199706000-00005 · Cited by 41 · see citing works
Nonsteroidal anti-inflammatory drugs in patients with inflammatory bowel disease
O’Brien, J. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.02241.x · Cited by 21 · see citing works
Wick, D. A., Seetharam, B., & Dahms, N. M. (1999) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1999.277.3.g506 · Cited by 7 · see citing works
Anti-TNF treatment restores the gut barrier in Crohn's disease
Suenaert, P., Bulteel, V., Lemmens, L., et al. (2001) · Gastroenterology · doi:10.1016/s0016-5085(08)82573-5 · Cited by 4 · see citing works
Rubin (2000) · doi:10.1002/1097-0029(20001015)51:2
Flagged first, then by citations
Cited by
Sorted by citations
Intestinal mucosal barrier function in health and disease
Turner, J. R. (2009) · Nature reviews. Immunology · doi:10.1038/nri2653 · Cited by 3,952 · see citing works
Physiology and function of the tight junction
Anderson, J. M., & Van Itallie, C. M. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a002584 · Cited by 1,059 · see citing works
Leonard, B., & Maes, M. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.12.005 · Cited by 805 · see citing works
Dietary metabolism, the gut microbiome, and heart failure
Tang, W. H. W., Li, D. Y., & Hazen, S. L. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0108-7 · Cited by 789 · see citing works
Maes, M., Leonard, B. E., Myint, A. M., Kubera, M., & Verkerk, R. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.12.017 · Cited by 700 · see citing works
Microbial tryptophan metabolites regulate gut barrier function via the aryl hydrocarbon receptor
Scott, S. A., Fu, J., & Chang, P. V. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2000047117 · Cited by 696 · see citing works
IL-1β Causes an Increase in Intestinal Epithelial Tight Junction Permeability
Al-Sadi, R. M., & Ma, T. Y. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.7.4641 · Cited by 601 · see citing works
Self-citationProbiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity
Ukena, S. N., Singh, A., Dringenberg, U., Engelhardt, R., Seidler, U., Hansen, W., Bleich, A., Bruder, D., Franzke, A., Rogler, G., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001308 · Cited by 482 · see citing works
Myosin light chain phosphorylation regulates barrier function by remodeling tight junction structure
Shen, L., Black, E. D., Witkowski, E. D., Lencer, W. I., Guerriero, V., Schneeberger, E. E., & Turner, J. R. (2006) · Journal of Cell Science · doi:10.1242/jcs.02915 · Cited by 467 · see citing works
Maes, M., Kubera, M., Leunis, J.-C., & Berk, M. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.02.023 · Cited by 446 · see citing works
Purohit, V., Bode, J. C., Bode, C., Brenner, D. A., Choudhry, M. A., Hamilton, F., Kang, Y. J., Keshavarzian, A., Rao, R., Sartor, R. B., et al. (2008) · Alcohol · doi:10.1016/j.alcohol.2008.03.131 · Cited by 325 · see citing works
Yu, M., Wang, Q., Ma, Y., Li, L., Yu, K., Zhang, Z., Chen, G., Li, X., Xiao, W., Xu, P., et al. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.22259 · Cited by 274 · see citing works
Al-Sadi, R., Guo, S., Ye, D., & Ma, T. Y. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.09.001 · Cited by 262 · see citing works
Self-citationTumour Necrosis Factor Alpha in Intestinal Homeostasis and Gut Related Diseases
Ruder, B., Atreya, R., & Becker, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081887 · Cited by 228 · see citing works
High-fat-induced intestinal permeability dysfunction associated with altered fecal bile acids
Stenman, L. K. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i9.923 · Cited by 201 · see citing works
Buschmann, M. M., Shen, L., Rajapakse, H., Raleigh, D. R., Wang, Y., Wang, Y., Lingaraju, A., Zha, J., Abbott, E., McAuley, E. M., et al. (2013) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-09-0688 · Cited by 192 · see citing works
Pan, Y., & Nicolazzo, J. A. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.04.009 · Cited by 131 · see citing works
Hu, J., Luo, H., Wang, J., Tang, W., Lu, J., Wu, S., Xiong, Z., Yang, G., Chen, Z., Lan, T., et al. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.122 · Cited by 126 · see citing works
Al-Sadi, R., Engers, J., Haque, M., King, S., Al-Omari, D., & Ma, T. Y. (2021) · PLOS ONE · doi:10.1371/journal.pone.0249544 · Cited by 93 · see citing works
Self-citationGarg, A., Zhao, A., Erickson, S. L., Mukherjee, S., Lau, A. J., Alston, L., Chang, T. K. H., Mani, S., & Hirota, S. A. (2016) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.234096 · Cited by 82 · see citing works
Guo, S., Chen, S., Ma, J., Ma, Y., Zhu, J., Ma, Y., Liu, Y., Wang, P., & Pan, Y. (2019) · Mediators of Inflammation · doi:10.1155/2019/5796491 · Cited by 64 · see citing works
Toll-like receptor-4 mediates intestinal barrier breakdown after thermal injury
Peterson, C. Y., Costantini, T. W., Loomis, W. H., Putnam, J. G., Wolf, P., Bansal, V., Eliceiri, B. P., Baird, A., & Coimbra, R. (2010) · Surgical Infections · doi:10.1089/sur.2009.053 · Cited by 47 · see citing works
Bile acid mediated effects on gut integrity and performance of early weaned piglets
de Diego-Cabero, N., Mereu, A., Menoyo, D., Holst, J. J., & Ipharraguerre, I. R. (2015) · BMC Veterinary Research · doi:10.1186/s12917-015-0425-6 · Cited by 35 · see citing works
Droessler, L., Cornelius, V., Markov, A. G., & Amasheh, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168746 · Cited by 18 · see citing works
da Silva, T. F., Glória, R. D. A., de Sousa, T. J., Americo, M. F., Freitas, A. D. S., Viana, M. V. C., de Jesus, L. C. L., da Silva Prado, L. C., Daniel, N., Ménard, O., et al. (2023) · BMC Microbiology · doi:10.1186/s12866-023-03112-4 · Cited by 11 · see citing works
- Authors
- Ma, T. Y., Boivin, M. A., Ye, D., Pedram, A., & Said, H. M.
- Affiliations
- University of New Mexico (US)
- Venue
- American Journal of Physiology-Gastrointestinal and Liver Physiology
- Publisher
- American Physiological Society
- Published
- 2005-03
- Volume
- 288
- Issue
- 3
- Pages
- G422-G430
- ISSN
- 0193-1857 (ISSN-L)
- 1522-1547
- OpenAlex
- W2136845685
- Cited by
- 452
- References
- 51
- Citations by year
- 2026: 10 · 2025: 12 · 2024: 20 · 2023: 25 · 2022: 21 · 2021: 32 · 2020: 20 · 2019: 22 · 2018: 24 · 2017: 26 · 2016: 32 · 2015: 23 · 2014: 17 · 2013: 23 · 2012: 26
- FWCI
- 9.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Physiology-Gastrointestinal and Liver Physiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK064165, R0-1-DK-64165–01)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Inflammatory Bowel Disease
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- TNF-α, myosin light chain kinase, tight junction permeability, intestinal epithelial barrier, Caco-2 cells, Crohn's disease, intestinal inflammation, cycloheximide, actinomycin D, gene expression regulation
- MeSH terms
- Antimetabolites, Cell Membrane Permeability, Dactinomycin, Humans, Methionine, Myosin-Light-Chain Kinase, Protein Synthesis Inhibitors, RNA, Messenger, Tumor Necrosis Factor-alpha, Blotting, Western, DNA Primers, Caco-2 Cells, Tight Junctions, Sodium Azide, Reverse Transcriptase Polymerase Chain Reaction, Immunoprecipitation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review